NCT02134054View on ClinicalTrials.gov

Stavanger IBD Study - Cross Sectional

Active, not recruitingOBSERVATIONAL
Enrollment

210

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

December 31, 2024

Conditions
Inflammatory Bowel Disease
Trial Locations (1)

4068

Stavanger University Hospital, Stavanger

All Listed Sponsors
collaborator

Rikshospitalet University Hospital

OTHER

collaborator

Oslo University Hospital

OTHER

lead

Helse Stavanger HF

OTHER_GOV